| Literature DB >> 32552900 |
Nilson Benedito Lopes1, Igor Vivian Almeida2,3, Pedro Henrique Silvestre Lopes4, Veronica Elisa Pimenta Vicentini5.
Abstract
BACKGROUND: Healthcare workers occupationally exposed to 18F-FDG cannot wear protective equipment, such as lead aprons, since the interaction between high energy radiation (511 keV) and metal increases the dose of radiation absorption. The objective of this study was to evaluate the shielding efficacy of a plastic polymer against the toxicogenomic effects of ionizing radiation in human lymphocytes, using cytokinesis-block micronucleus assays.Entities:
Keywords: Fluorodeoxyglucose; Human biomonitoring; Increased individual protection; Micronucleus; Radiological shielding
Mesh:
Substances:
Year: 2020 PMID: 32552900 PMCID: PMC7301467 DOI: 10.1186/s13014-020-01598-0
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Fig. 1Schematic illustration of the lead + polymer shielding test
Fig. 2Schematic illustration of the lead + polymer shielding during exposition to ionizing radiation
Absolute values (counts per minute ✕ 1000) measured in a Geiger-Müller detector for the radiopharmaceutical 18F-FDG, with lead and polymer shields
| Distance | Unshielded | Lead | Polymer | Polymer + Lead | Lead + Polymer | |
|---|---|---|---|---|---|---|
| sat | sat | sat | sat | sat | ||
| sat | sat | sat | sat | sat | ||
| 225 | 229,9 | 185 | 226,8 | 171,9 | ||
| 30 | 34,8 | 27,4 | 31,8 | 24,7 | ||
| sat | sat | sat | sat | sat | ||
| sat | sat | 266 | sat | 252 | ||
| 134 | 142 | 106,2 | 134 | 96,8 | ||
| 26,8 | 28,4 | 21,2 | 27 | 20,8 | ||
| 163 | 176 | 130,2 | 172,4 | 121,3 | ||
| 89 | 90,4 | 73,3 | 86 | 65,1 | ||
| 34 | 38 | 25,3 | 35 | 22,6 | ||
| 4 | 3,8 | 3,8 | 3,8 | 3,5 |
A: radioactive activity of the element. Sat: saturation of the monitor, making measurement impossible
Induction of micronuclei by ionizing radiation of 18F-FDG in human lymphocytes in vitro
| Shielding | Distribution of BNC according to the number of MN | MN/BNC ± SD (%) | CMN/BNC ± SD (%) | NPB/CBN ± SD (‰) | NBUD/CBN ± SD (‰) | CBPI ± SD | |||
|---|---|---|---|---|---|---|---|---|---|
| Negative Control | 14 | 1 | 0 | 0 | 1.55 ± 0.19 | 1.48 ± 0.18 | 1.00 ± 0.63 | 0.83 ± 0.75 | 2.09 ± 0.05 |
| 18F-FDG Unshielded | 53 | 3 | 2 | 2 | 7.13 ± 0.70a | 5.92 ± 0.68a | 5.83 ± 0.75a | 4.67 ± 1.75a | 1.60 ± 0.06a |
| 18F-FDG + Lead | 39 | 2 | 1 | 1 | 4.78 ± 0.33ab | 4.22 ± 0.19ab | 1.17 ± 0.75b | 0.50 ± 0.55b | 1.99 ± 0.03ab |
| 18F-FDG + Polymer | 46 | 3 | 1 | 1 | 6.02 ± 0.20ab | 5.10 ± 0.14ab | 2.50 ± 1.05ab | 1.83 ± 0.75ab | 1.88 ± 0.04ab |
| 18F-FDG + Lead + Polymer | 38 | 1 | 1 | 0 | 4.30 ± 0.23ab | 3.98 ± 0.23ab | 1.50 ± 0.55b | 0.83 ± 0.75b | 2.06 ± 0.04b |
Number of binucleated cells analyzed for each individual in each repetition = 1000
BNC binucleated cells, MN micronucleus, CMN cell with one or more micronuclei, NPB nucleoplasmic bridge, NBUD nuclear bud, CBPI Cytokinesis-Block Proliferation Index
a Statistically significant difference from the negative control (p < 0.05)
b Statistically significant difference from the unshielded group (p < 0.05)
Fig. 3Cell proliferation and DNA-induced damage in human peripheral blood lymphocytes. a mononucleated cell. b binucleated cell. c polynucleated cell. d binucleated cell with one micronucleus. e binucleated cell with two micronuclei. f binucleated cell with nucleoplasmic bridge. g binucleated cell with nuclear bud. Magnification: 1000✕